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Abstract 
Despite nearly a half-century of study, the clinical 
value of spontaneous crystalluria (Cx) examinations in 
calcium stone formers (CaSF) is still uncertain. The an-
alytical complexity of urine particle study is largely re-
sponsible for this situation. As a result, there is no con-
sensus regarding technical methods in Cx with several 
techniques for urine sampling and three different instru-
ments currently used for particle study, namely, particle 
counting (PC), light microscopy (LM) and petrographic 
microscopy (PM). In this work, we first examined urine 
sampling and instrument methods regarding their appro-
priateness for Cx studies. Then we performed a com-
parative analysis of Cx studies in CaSF. Despite many 
technical and clinical discrepancies, several studies agree 
that the frequency of "all particles" and of the weddellite 
and whewellite calcium oxalate (CaOx) crystalline 
phases are increased in CaSF as compared to normal 
subjects (NS). Particle sizes and aggregation ratio are 
also often increased. Altogether, these results reinforce 
the need for an efficient method for Cx studies in these 
patients. Examining each technique leads us to conclude 
that most particle parameters can be studied by "direct 
LM" observation of freshly voided urine samples, i.e., 
urine samples without any separation steps. For clinical 
applications, several examinations should be performed, 
first to define the specific Cx characteristics in a patient, 
then for the study of treatment efficiency on Cx control, 
and finally, during the patient follow-up. Due to Cx 
variability in each patient, the frequency of Cx examina-
tions during each phase needs to be determined in long-
term comparative prospective studies of CaSF. 
Key Words: Calcium stone formers, crystalluria, urine 
sampling, particles counting, petrography, light micros-
copy, patient follow-up. 
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Introduction 
The annual incidence of calcium oxalate urolithiasis 
in western societies ranges between 7 and 21 per 10,000 
(Smith, 1989). Consequently, medical and socio-eco-
nomic consequences of urolithiasis call for new strate-
gies for its prevention (Consensus conference, 1988). 
Among these strategies, the finding of crystalline parti-
cles 1 in urine of calcium stone formers (CaSF) long ago 
raised strong hopes for the potential usefulness of crys-
talluria (Cx) examinations in these patients: From "the 
most ancient times there was a persuasive belief that Cx 
and stone formation are somehow related" (Hallson, 
1988). It was, therefore, expected that Cx studies could 
give information about the calcium lithiasis processes at 
work in CaSF: "Since the crystals observed in urine 
have grown in the urinary tract, they should be subject 
to at least some of the same factors involved in urolithia-
sis" (Wemess et al., 1981). Finally, hopes that Cx 
studies could be of diagnostic value, in particular for the 
prediction of stone recurrence and for patient follow-up, 
were the greatest incentives of almost one-half century 
of Cx research in CaSF (Black, 1945). Nevertheless, 
the interest of Cx studies in these patients is still not 
firmly established. Most disturbing from the beginning 
of these studies were the observations that Cx episodes 
could be observed both in CaSF and in healthy subjects 
in whom no renal stone disease had been recognized 
(Cottet and Vittu, 1952; Robertson, 1969; Robertson et 
al., 1969), showing that there is no "one-to-one" corre-
spondence between Cx and stone formation processes 
(Wemess et al., 1981). The main difficulties encounter-
ed during Cx studies, however, are a series of technical 
and instrumental problems related to both urine sampling 
and processing, and to the instruments used for particle 
studies. In this paper, we analyzed these difficulties, the 
methods developed to solve them, and the results of Cx 
examinations in CaSF. We finally suggest that "direct 
light microscopy (LM)" study of urine samples is a sim-
ple, reliable and efficient method for Cx studies. 
1The term "particle(s)" is used to cover both crystals and 
aggregates when a distinction is not relevant. 
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Figure 1 (a-hon the facing page 217; i-p on page 218). Light microscopic illustrations of calcium oxalate crystals, 
crystal aggregates and associations most frequently found in urine of CaSF. From top to bottom and clockwise. la. 
Whewellite in oval crystals with swollen extremities ("dumb-bell"). lb. Whewellite in pseudohexagonal habit dispersed 
among a background of granulations made of amorphous complex urates (polarized light). le. Whewellite aggregates 
of pseudohexagonal crystals with granulations of amorphous complex urates. ld. Whewellite in "lenticular" or "hema-
tiform" habit associated with brushite aggregates (arrow) and amorphous carbonated calcium phosphates (ACCP) granu-
lations. le. Whewellite in sticks with straight or slightly swollen sides in a background of amorphous complex urates 
(polarized light). lf. Whewellite in hexagonal crystals with a stretched appearance encountered during ethylene glycol 
intoxication (polarized light). lg. Weddellite in bipyramid crystals ("envelope"). lb. Weddellite bipyramid crystals 
in aggregates with 2 macles. Bars = 16 µm (for la to lf, and lh) and 65 µm (for lg). 
Particle parameters 
Cx studies primarily involve the qualitative and 
quantitative study of urinary particles using a range of 
appropriate parameters. These parameters are briefly 
examined below. 
Particle qualitative parameters 
Crystalline phases: In aqueous solutions supersatu-
rated with CaOx, crystals corresponding to the three hy-
drated CaOx salts are observed. In urine, which is nor-
mally supersaturated with all three hydrates (Gardner, 
1975), crystalline particles corresponding to monohy-
drate salt, or whewellite, and to dihydrate salt, or wed-
dellite, are observed. CaOx trihydrate, the least stable 
and most soluble phase, which may occur transiently at 
the time of initial precipitation (Tomazic and Nancollas, 
1979), is found in urine in rare situations such as after 
certain drug treatments (Daudon et al., 1987b). In addi-
tion to the CaOx crystalline phases, several others, in-
cluding uric acid and urate salts, calcium phosphates and 
struvite, are observed in urine of CaSF. 
Crystalline phase habits: In vivo, as in chemical 
solutions, each crystalline phase can be present under 
several habits since growth conditions are not necessarily 
the same for all sides of the crystal (Nancollas, 1979, 
1983). The presence of particles with the same crys-
talline molecular phase but with different habits can 
lead, if unknown, to the risk of Cx misinterpretations 
(Osborne et al., 1986). In a few cases, specific crystal 
habits have been related to particular situations such as 
the dodecahedral habit of weddellite crystals observed in 
highly hypercalciuric urine samples in place of the com-
mon octahedral habit (Daudon, 1987a) and the whewel-
lite habit observed after ethylene glycol poisoning with 
a habit strikingly different from the usual oval or dumb-
bell habits (Godolphin et al., 1980; Miller, 1990; 
Terlinsky et al., 1980, 1981). 
Aggregates: Due to physico-chemical interactions, 
crystals can join together in polycrystalline structures or 
"aggregates". These formations can include various 
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numbers of crystals and be composed of one or several 
crystalline phases. 
Particle morphology: Isolated urinary crystals and 
aggregates are frequently identified using either LM 
(Baumann, 1978; Coe et al., 1992; Elliot et al., 1976; 
Osborne et al., 1986) or scanning electron microscopy 
(SEM) (Berg et al., 1976; Edyvane et al., 1987; Khan 
and Hackett, 1986; Rodgers et al., 1988; Werness et 
al., 1981). However, in clinical practice, urinary parti-
cles are mostly found in various associations such as 
whewellite and weddellite, weddellite and uric acid, 
weddellite and brushite, and amorphous calcium phos-
phate, etc., which are rarely illustrated (Daudon, 1989, 
1993; Valyasevi and Dhanamitta, 1974). Other qualita-
tive observations which may be of interest for Cx inter-
pretation concern the presence of heterogeneous nuclea-
tion processes observed on epithelial linings, cell debris, 
urinary casts, etc. (Coe et al., 1992). The main particle 
habits, their associations and some frequently encounter-
ed nucleations in urine of CaSF are illustrated in Figures 
1 and 2. 
Particle quantitative parameters 
Sizing: Particles in urine are present in a wide 
range of sizes and are not easily measurable (see Figs. 
1 and 2). To obtain a representation of the particle sizes 
in a urine sample, several indicators such as the mean 
particle size, the maximal particle size, and the size-
number distribution spectrum are used. 
Abundancy: Cx abundancy can be quantified using 
the particle number and volume. 
Aggregation ratio 
An aggregation ratio is computed as the number of 
aggregates divided by the total number of particles in a 
sample. 
Particle frequency 
Particle frequency relates to the mere presence or 
absence of particle(s) in a urine sample. Theoretically, 
Methods for crystalluria studies in calcium stone formers 
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Figure 1 (legend continued from page 216). From top to bottom and clockwise. li. Weddellite in truncated pyra-
mids with a rectangular-deformed base. lj. Weddellite in dodecahedral faces giving an hexagonal appearance usually 
associated with hypercalciuria (Ca > 6 mmol/l) (polarized light). lk. Weddellite crystal in square habit with two 
opposite triangles at the inside (polarized light). ll. Large weddellite aggregate composed of about 50 crystals. lm. 
Trihydrated calcium oxalate asymmetric hexagonal habit in thin lamella. ln. Trihydrated calcium oxalate in thick plate 
("race course"). lo. Mixed crystalluria of whewellite crystals in "dumb-bell" and octahedral weddellite crystals in a 
voluminous aggregate (polarized light). lp. Whewellite ( oval) and weddellite ( envelope) in a voluminous heterogeneous 
aggregate (polarized light). Bars = 16 µm (for li to ln, and lp) and 65 µm (for lo). 
















the observation of a single particle is sufficient to qualify 
an urine sample as "Cx positive". It has long been 
known that, even in recurrent CaSF, urine samples are 
not always "Cx positive" (Cottet and Vittu, 1952; 
Robertson et al., 1969). Conversely, urine samples 
from normal subjects (NS), i.e., people without any 
known stone and/or renal disease, are not always "Cx 
neg,:tive", i.e., free of particles. These observations can 
be quantified using the frequency parameter, i.e., the 
number of "Cx positive" samples over the total number 
of samples in a series. Frequency can be studied for the 
presence of particles in urine whatever the chemical 
composition giving an "all particles" frequency. Fre-
quency can also be studied separately for each crystalline 
phase, for example, for the weddellite phase, the brush-
ite phase, etc., as well as for association, such as urate 
and weddellite phases. 
Other crystalluria parameters 
To fully describe a urine sample regarding its crys-
tallization status, study of urine particles is necessary but 
not sufficient. Other urine variables must be used, in 
particular, the biochemical variables as well as physico-
chemical variables such as supersaturation (Robertson et 
al., 1976a, 1981; Tiselius, 1991; Werness et al., 1985) 
which, in the final analysis, are responsible for crys-
tallization. All these variables are of great help for the 
final step of Cx interpretation (Daudon, 1987b, 1993; 
Urine biochemical Urine physico-chemical 
variables variables 
calcium; oxalate pH; density; ionic strength 
phosphate; urate conductivity 
citrate; sulfate; sodium; supersaturation 
potassium; magnesium; 
pyrophosphate; urea; creatinine 
macromolecular inhibitors crystallization 
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inhibition power 
Robertson et al., 1981). The main Cx particles and 
urine associated variables are grouped in Table 1. 
Instruments for Particle Studies 
The instruments used for clinical application of Cx 
belong to three different families: light microscopy 
(LM), petrographic microscopy (PM) and particle count-
ing (PC). For each instrument, its principle, the sample 
preparation method, and the particle parameters which 
can be studied are discussed below. The heading Feasi-
bility covers the skills required by operators, time per 
sample, and the associated costs. 
Light microscopy (LM) 
Principle: Observation is made by optical light 
transmission. To improve differentiation between crystal 
habits, polarized light observation was introduced for 
particle identification (Dyer and Nordin, 1967). 
Sample preparation: In most LM studies, "indi-
rect LM" is performed on a 10-20 µl aliquot of the sedi-
ment obtained after isolation of the particles by filtration 
or centrifugation of a 1-2 ml aliquot of the urine sample. 
"Indirect LM" on sieved fractions of urine were also 
used in the past (von Sengbusch and Timmermann, 
1957a,b, 1958). In ourlaboratory, we developed "direct 
LM" studies of urinary samples. In this method, the 
particles are studied as voided using a 20 µl aliquot of 
C.A. Bader et al. 
Figure 2. Mixed crystalluria in CaSF. From top to bottom and clockwise. 2a. Whewellite ( oval) crystals associated 
with complex amorphous urates in granulations (polarized light); 2b. Heterogeneous crystalluria with whewellite, wed-
dellite (macle) and dihydrated uric acid (arrows) (polarized light). 2c. Heterogeneous nucleation of octahedral weddel-
lite crystals (arrows) on anhydrous uric acid (polarized light). 2d. Heterogeneous nucleation of whewellite in stick 
crystals on anhydrous uric acid crystals (polarized light). 2e. Heterogeneous nucleation ofbrushite (arrows) on dodeca-
hedral weddellite with amorphous calcium phosphates in granulations. 2f. Heterogeneous nucleation of brushite over 
weddellite and, conversely, of weddellite over brushite. 2g and 2h. Heterogenous crystalluria with whewellite, struvite 
and granulations of amorphous calcium phosphate (2g), and with weddellite, struvite and granulations of amorphous 
calcium phosphate (2h). Bars = 30 µm (for 2a, 2b, 2d, 2g, and 2h); 65 µm (for 2c and 2e); and 16 µm (for 2f). 
a well-homogenized urine placed in a Mallassez cell as 
for cytological studies (Daudon, 1987a, 1989; Daudon 
et al., 1983, 1987a; Nguyen et al., 1987). 
Particle study: Qualitative parameters: Using 
LM, all particle qualitative descriptors can be studied: 
crystalline phases and habits, aggregates, etc. 
Particle study: Quantitative parameters: 
Sizing: Sizes of particles are studied using a 
graduated eye-piece ocular and are limited only by the 
resolution limit of LM, i.e., 1 µm. 
Particle abundancy: The total particle number 
and concentration are measured by taking into account 
the urine sample and cell chamber volumes. Particle 
volume is not usually measured by LM although an ap-
proximation can be obtained in certain cases (see 
Discussion). 
Aggregation: Composition and number of ag-
gregates can be recorded. From the total particle num-
ber and the aggregate number, the aggregation ratio can 
be computed. 
Feasibility: A well-trained technician is able to 
reliably and rapidly recognize most crystalline phases in 
their various habits. An extensive qualitative and quanti-
tative "direct LM" Cx study is performed by an experi-
enced observer in about 15-20 minutes. This time must 
be at least be doubled when using "indirect LM", due to 
the required technical handling of the sample. A good-
quality polarized light microscope with several magnifi-
cation lenses costs about $12,000; when equipped for 
microphotography and video imaging, the cost totals 
about $20,000. 
Petrography microscopy (PM) 
Principle: PM performs crystalline phase determi-
nation by comparing the refraction index of the particles 
with the known refraction indices of organic oils. 
Sample preparation: PM requires full isolation of 
the particles using several filtration and drying steps. 
Particle study: Qualitative variables: With PM, 
the crystalline chemical phases of the main particle can 
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be studied. The characteristic refractive indices are 
associated with a given crystalline phase. 
Particle study: Quantitative variables: 
Particle number: Following the work of 
Wemess et al. (1981) semi-quantitative results are ob-
tained using a scale based on the observed number of 
crystals per filter from a 2 ml sample. A scale is used 
to attribute a score for quantifying the particles collected 
on the filters: 0 crystals (i.e., "negative" crystalluria) 
= O; 1-200 = 1+; 200-500 = 2+; > 500 = 3+. 
Summing the scores from the individual voidings and di-
viding the obtained value by the number of voidings dur-
ing the 24-hour collection period provides the "crystal-
luria score". 
Particle sizes: These parameters are not 
usually studied in Cx studies with PM. 
Feasibility: PM requires full isolation of the 
particles involving lengthy preparation steps. PM obser-
vation is a relatively sophisticated method and requires 
expert technicians. The costs of PM instruments are 
similar to those for LM. 
Particle counting (PC) 
Principle: The principle of these instruments is 
based on a modification of an electric parameter trig-
gered by particles coming across the detector chamber. 
Sample preparation: Use of PC in Cx studies was 
introduced by Robertson (1969). A prefiltration step of 
the samples is needed to eliminate particles with sizes 
greater than 74 µm which would plug the inlet of the in-
strument. Furthermore, the particles have to be put in 
suspension in an electrolyte. Since every particle which 
passes across the measuring cell will be recorded irre-
spective of its nature, a technique for special handling of 
sample has been developed for counting the CaOx parti-
cles only. Two samples are run in parallel: one is 
ethylenediaminetetraacetic acid (EDT A) treated to dis-
solve the calcium oxalate and phosphate crystals; its 
companion sample is similarly treated except that the 
EDT A is replaced with a saline solution. The difference 
between the two counts is taken as the neat calcium 
Methods for crystalluria studies in calcium stone formers 
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oxalate crystal number. 
Particle parameters: Qualitative variables: No 
direct information regarding the particle can be obtained 
using PC. 
Particle study: Quantitative variables: 
Particle sizing: Particles above 3.8 µm were 
recorded by Robertson (1969), although a smaller size 
(2.5 µm) has also been recently observed (Rodgers et 
al., 1991). 
Particle quantitation: A size-number distribu-
tion spectrum is recorded over the range 3.8-48.6 µm. 
Standardization of the apparatus permits derivation of a 
volume-size distribution spectrum. Then, a crystal 
volume per unit volume of urine or "volume-concentra-
tion" is computed. 
Feasibility: PC are easy to use and can be 
equipped with a data treatment facility. Although the 
instrumental counting step is rapid, sample manipulations 
require a long time. Cost of instruments is from about 
$15,000 to 30,000 depending on automation and comput-
ing facilities. 
Other instruments for particle studies 
Physical methods must be used for the study of 
crystals less than 1 µm as for most calcium phosphate 
crystals (Tozuka et al., 1987). Definite identification of 
the major habits of urinary CaOx crystals has also been 
made using crystallographic analysis (Catalina and 
Cifuentes, 1970a,b). These methods are also used for 
unusual crystal habits, e.g., thin needles seen in urine 
after ethylene glycol poisoning which were first assumed 
to be hippurate crystals but were later identified, thanks 
to X-ray diffraction, as whewellite crystals (Godolphin 
et al., 1980). SEM, with its large depth of focus, 
shows the morphological features of crystals and has 
been used for illustrating CaOx crystals in urine in many 
studies. X-ray diffraction crystallography, and SEM 
alone or coupled with an energy dispersive X-ray micro-
analysis systems, are also sometimes used in clinical 
studies. In our laboratory, we showed that infrared 
spectrophotometry alone or coupled to an infrared 
microscope for individual crystals with sizes above 8 µm 
allows rapid identification of molecular phases (Daudon 
et al., 1991). Chemical methods have also been devised 
for calcium oxalate and phosphate crystal determination 
in urine (Hallson and Rose, 1988). 
Urine Sampling and Processing 
Urine biochemical composition and saturation, i.e., 
the crystallization "driving forces", are highly variable 
(Finch et al., 1981; Robertson and Peacock, 1984; 
Robertson et al., 1972, 1976a). As a result, Cx varies 
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with diet (Cottet and Vittu, 1952), beverages consumed, 
drinking habits (Black, 1945), and volume of liquid in-
take (Black, 1945; Berlyne et al., 1976). The post-pran-
dial alkaline tide may favor formation of calcium phos-
phate nuclei on which calcium oxalate can crystallize 
(Schwille, 1985). Many other variables, such as, sea-
sons (Hallson and Rose, 1977), physical activity (Irvine 
et al., 1986; Rodgers et al., 1988, 1991), and ethnic 
group (Rodgers et al., 1992; Valyasevi and Dhanamitta, 
1974) can influence Cx. Another source of Cx variabili-
ty is urine instability with particles in equilibrium with 
a supersaturated liquid phase. As soon as the urine is 
voided, any change in temperature and composition 
could easily alter this equilibrium with risks for the na-
tive particles to be modified qualitatively and quantita-
tively. Thus, in order to perform reliable comparisons 
between Cx data, a sampling protocol able to control 
both for patient variability and urine instability has to be 
chosen. 
Urine sampling 
In order to control for patient variability, most 
primary studies were performed with strict control of 
patient conditions (Robertson et al., 1969). Patient 
preparations with regimen loaded in oxalate, calcium and 
carbohydrates were also used while allowing metabolic 
lithiasic dysfunction to be revealed by inducing or in-
creasing Cx in these subjects (Cottet and Vittu, 1952, 
1953; Robertson and Peacock, 1972; von Sengbusch and 
Timmermann, 1958). In more recent studies, first urine 
of the morning, which is more concentrated due to night 
water restriction, is favored (Daudon and Reveillaud, 
1984; Daudon et al., 1983, 1987a; Hermann and 
Schwille, 1992; Sriboonlue et al., 1990). 
Urine storage 
In the context of clinical studies, a storage period 
between patient voiding and examination is generally un-
avoidable. There is no consensus as to the duration and 
temperature which would entail no significant modifica-
tion of the spontaneous Cx properties. In many studies, 
great care is taken to avoid any temperature variations 
from the time of voiding to the time of examination, by 
collecting urine at 37°C and conducting all the technical 
processes and instrument examination at this tempera-
ture. These conditions are not easy to comply with in 
routine clinical practice and several laboratories ques-
tioned the stringency of these conditions. Several au-
thors estimated that urine samples stored for up to 2 
hours showed no significant change in urine composition 
or bacterial effects on crystallization (Hallson and Rose, 
1977). Recording samples pH just after voiding, and 
then at the time of study, allows one to record any 
changes due to bacteria (Daudon et al., 1983). In these 
conditions, no changes in mean particle sizes of samples 
Methods for crystalluria studies in calcium stone formers 
Table 2. Frequency of "all particles" and CaOx particles in CaSF and NS. 
Reference 
Cottet and Vittu (1952) 
Hallson and Rose (1976) 
Baumann et al. (1984) 






Wemess et al. (1981) PM 
Caudarella et al. (1986) PM 
K.lepikov et al. (1991) "indirect LM" 
































3p < 0.001 
-------------------------------------------------------------------------
Table 3. Frequency(%) of the accompanying phases in urine of CaSF. 
Reference 
Cottet and Vittu (1953) 
Hallson and Rose (1976) 
Wemess et al. (1981) 
Caudarella et al. (1986) 
Klepikov et al. (1991) 















Calcium phosphate (brushite, 







Table 4. Maximum sizes of CaOx single crystals and aggregates (in µm) observed in urine of CaSF and NS. 
Reference 
von Sengbusch and Timmermann (1958) 
Dhanamitta et al. (1970); Valyasavi et al. (1973) 
Hallson and Rose (1976) 
Buli et al. (1982) 
Baumann (1978); Baumann et al. (1984) 
K.lepikov et al. (1991) 
Daudon et al. (unpublished) 


















120± 16/32±45 1 296±40/88±41 2 
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Table 5. Particle aggregation ratio in CaSF and NS as 
observed by LM studies. 
Reference 
Sriboonlue et al. (1990) 
Hallson and Rose (1976) 








stored up to two hours at 22 and 37°C (Elliot and 
Rabinowitz, 1980) or in sizes and aggregation ratios of 
samples stored 3-4 hours at room temperature (Fazil 
Marickar et al., 1988) were observed using LM. Using 
PC, a shift towards lower volume-size distribution 
curves was observed but only after urine storage for 3 
hours at 27°C (Irvine et al., 1986). When the whole 
urine sample was used without dilution and acid treat-
ment, it was observed that the number of crystals 
changed rapidly as a function of temperature and time 
(Adamthwaite, 1983a,b). These variations were attrib-
uted to the numerous tiny calcium phosphates crystals 
that are in suspension in urine (Ahlstrand et al., 1984). 
Results of Cx Studies in CaSF 
In this section, Cx studies in CaSF are classified by 
instrument family. According to the authors' own con-
clusions, they are further divided into "Cx proponents" 
and "Cx opponents" regarding interest of Cx in CaSF. 
The main results from the "proponents" are grouped in 
Tables 2-5. 
LM studies 
"Proponents": One of the first studies was per-
formed on members of a military unit stationed in India 
(Black, 1945). The author identified two types of CaOx 
crystals, one with "octahedral or envelope" form and the 
other with a "dumb-bell or biscuit" form. These crystals 
were later recognized as the main habits of weddellite 
and whewellite, respectively. Black (1945) further noted 
that Cx episodes were related to oxaluria, low water in-
take and "a lot of strong tea" consumption. He con-
cluded that oxalate crystals can be passed in the urine 
"for years without any tendency to calculus formation". 
Cottet and Vittu (1952, 1953) performed, apparently for 
the first time, comparative Cx studies between CaSF and 
NS after a dinner with water restriction. These studies 
gave the first quantitative evaluation of Cx frequencies 
both in CaSF and NS for "all particles", CaOx and ac-
companying phases (Table 2). First attempts to study 
particle sizes and number using LM were performed by 
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studying the particles sieved from urine samples on fil-
ters with several mesh sizes. (von Sengbusch and Tim-
mermann, 1957a,b, 1958). It was shown that intake of 
food-stuffs with a high oxalate content causes increased 
excretion of "microstones", i.e., large crystalline aggre-
gates with sizes up to 200-700 µm in conjunction with 
single crystals. In studies performed in Thailand 
(Dhanamitta et al., 1967, 1970; Valyasavi and Dhana-
mitta, 1974, Valyasavi et al., 1967, 1973) where chil-
dren living in rural areas suffer from bladder lithiasis, 
CaOx crystals were "commonly found" in urine. A die-
tary survey showed that children in villages were eating 
local vegetables rich in oxalate, contrary to children in 
urban areas. Results of studies performed between chil-
dren eating oxalate-rich vegetables versus control chil-
dren fed with mother's milk, water and rice showed that 
numerous medium (10-20 µm) and large (25-80 µm) 
crystals as well as numerous aggregates up to 500 µm 
were observed with a much higher frequency in the chil-
dren eating oxalate-rich foods. In Great Britain, Hallson 
and Rose (1976) observed an "all crystals" Cx frequency 
of 48 % in CaSF versus 22 % in NS. Aggregation of 
Ca Ox crystals occurred in 8 % of urine samples from un-
treated stone formers compared to 2 % for urine samples 
of NS. Hallson and Rose (1976) also performed quanti-
tative Cx studies using PC (see below). Later, Hallson 
and Rose (1978) introduced an evaporation method for 
studying urine crystallization properties. In Germany, 
microphotographs of urine sediments were taken after 
giving an oxalate oral dose to 18 recurrent active CaSF 
and 16 NS (Baumann, 1978). It was shown that 9 pa-
tients formed aggregates with diameters above 50 µm in 
the urine against only 1 subject in the NS group. More 
recently, Baumann et al. (1984) studied 12 idiopathic re-
current CaSF and 16 NS after oxalate ingestion. A 140 
µm maximum size for weddellite crystals was observed 
in CaSF against 30 µm for NS. Similarly, Cx frequency 
was 25 % in NS against 80-90 % in CaSF after oxalate 
ingestion. All groups responded to oxalate loading with 
a considerable increase in whewellite particles. 
All the preceding studies were performed using "in-
direct LM", i.e., on urine particles isolated after several 
technical steps. In the last few years, "direct LM" stud-
ies of the urine particle were initiated in France by 
Daudon and his co-workers (Daudon, 1993; Daudon and 
Reveillaud, 1984; Daudon et al., 1983, 1987a,b, 1989; 
Nguyen et al., 1987). Cx particle parameter studies 
were performed using first urine samples of the morning 
collected at room temperature and examined in the two 
hours following voiding. These studies have been per-
formed in a continuously growing patient data base cur-
rently composed of 328 CaSF and 123 NS. The main 
results concern the frequency of the various crystalline 
phases, sizes and aggregation ratios. The relationship 
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between whewellite and oxaluria was confirmed and the 
respective role of calcium and oxalate urinary concentra-
tion on the control of CaOx phases were analyzed. It 
was found that the voided CaOx molecular phases de-
pend on the calcium/oxalate molar ratio with weddellite 
and whewellite particles nearly exclusively present for 
calcium/oxalate ratio values over 14 and under 5, re-
spectively. On the contrary, CaOx Cx frequency is de-
pendant on the urinary calcium oxalate molar concentra-
tion product (Daudon and Reveillaud, 1984; Daudon et 
al., 1989). In a recent Russian study of 372 nephrolithi-
asis patients, Klepikov et al. (1991) found urinary crys-
tals in 44 % of the patients against 17 % of "symptomless 
subjects"; accordingly, they suggest consideration of Cx 
"as a preclinical manifestation of urolithiasis". 
"Opponents": One of the most cited reports in the 
field of Cx studies in CaSF is from Dyer and Nordin 
(1967) who studied urine samples from 10 male hyper-
calciuric stone-formers; these urine sample were kept at 
37°C "until crystals were observed". The only crystals 
which were observed were calcium oxalate and "one 
form of calcium phosphate". There were "no clear dif-
ference between stone-formers and controls" with regard 
to the voided crystalline phases. Elliot and co-workers 
(Elliot and Rabinowitz, 1976; Elliot et al., 1976) studied 
122 hospital urine samples from patients with no evi-
dence of past stone disease. They used light and polar-
ized microscopy and studied crystal molecular phases, 
habits and sizes. The two main weddellite habits, the 
bipyramids and the dodecahedral forms and the whewel-
lite habits, with oval and dumb-bell forms, were recog-
nized. Particle sizes were shown to be from 2 to 22 µm 
for whewellite and 2 to 40 µm for weddellite. In an-
other study, Elliot and Rabinowitz (1980) studied crys-
tals size by structure and habit in urine samples from 27 
NS and 22 SF and found that "the mean crystal size did 
not support the conclusion that SF excrete larger crystals 
than normal subjects". They concluded that "there was 
no correlation between crystalluria and severity and dur-
ation of disease". Winkens et al. (1988) studied the 
urinary sediments from 148 SF and 144 NS and found 
that CaOx was the "predominant" crystal phase but 
found no difference between SF patients and NS for 
particle frequencies, numbers or sizes; they concluded 
that this examination is "without clinical value". 
PM studies 
"Proponents": Smith and colleagues (Smith, 1976; 
Van Den Berg et al., 1976) developed PM studies in li-
thiasic patients. In the first series, they studied 8 
patients with primary hyperoxaluria and 14 matched nor-
mal subjects. The frequency of crystalluria was 91 % in 
patients against 18 % in NS; the crystals were whewellite 
with sizes up to 100 µ.m "with evidence of aggregation". 
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The best documented PM study is by Wemess et al. 
(1981) in which 2524 voidings were studied: 202 urine 
samples from 16 NS, 686 samples from 47 primary 
hyperparathyroidism patients, 182 samples from 12 
primary hyperoxaluria and 1454 samples from 89 idio-
pathic CaSF. Crystal numbers voided during 3 consecu-
tive 24-hour periods were quantified using a "semi-
quantitative score" as described in Particle number 
under Petrographic microscopy section. It was shown 
that all patients, and CaSF in particular, had significant-
ly greater crystalluria scores than NS (p < 0.001). 
CaOx molecular phases appear to be under the control 
of oxaluria, and patients with primary hyperoxaluria had 
100 % of voidings with major or only whewellite crys-
tals. In idiopathic CaSF, weddellite was 45 % against 
8 % whewellite. Surprisingly, whewellite was observed 
in 18 % of NS but no wedddellite. Buli et al. (1982) 
studied Cx parameters including crystal number, sizes, 
and number of aggregates in 50 CaSF; these variables 
increased significantly in CaSF as compared to NS. 
More recently, Caudarella et al. (1986) studied 86 re-
current CaSF and 40 NS. It was observed that Cx was 
composed of weddellite "most frequently" in CaSF, 
whewellite being found less frequently (9 % ) whereas 
weddellite was "nearly exclusively" found in Cx of NS. 
"Opponents": In recent studies (Hermann and 
Schwille, 1992; Hermann et al., 1991), 78 male and 38 
female idiopathic recurrent CaSF were studied. Unex-
pectedly, CaOx crystals were either never or "only spo-
radically" seen in patients with pure CaOx or mixed 
CaOx-phosphate stones. Hermann and Schwille (1992) 
concluded that "calcium oxalate crystalluria does not 
qualify as a diagnostic aid". 
PC studies 
"Proponents": The use of PC for Cx studies was 
launched in 1969 and the method has been extensively 
applied (Robertson, 1969; Robertson and Peacock, 1972; 
Robertson et al., 1969, 1971, 1974, 1976a,b). Idiopath-
ic recurrent CaSF and NS in the same conditions of diet 
and fluid intake were studied. A higher "volume-con-
centration" of crystals (mm3 crystal/ml urine) was noted 
in CaSF. This increase was attributed to a greater aver-
age crystal size in CaSF and not to the particle number. 
Crystals excreted by controls were small (3-4 µm in di-
ameter) with little or no aggregates, whereas, recurrent 
SF passed, in addition to small crystals, larger crystals 
(10-12 µm) as well as polycrystalline aggregates (from 
20 to 300 µm). Robertson et al. (1972) refined the par-
ticle size-distribution relationship and showed that 
"whereas the normal control excreted his calcium oxalate 
as a unimodal distribution of small particles, the stone-
former had in addition a second peak of much larger 
particles". In addition to a peak centered around 7-8 
C.A. Bader et al. 
µm, a second peak of much larger particles (20-40 µm 
in diameter) was found in CaSF. Using a dividing line 
set at 12.2 µm, an oral load of oxalate given to a CaSF 
resulted in the appearance of a dramatic second peak, 
contrary to NS who showed no increase. Using LM, the 
larger particles were identified as weddellite crystals and 
were often found to occur in aggregates up to 200 µm in 
diameter. The same authors studied the relation between 
the percentage of large crystals and aggregates of cal-
cium oxalate with sizes arbitrarily set as 12 µm with an 
index taking into account both urine CaOx supersatura-
tion and inhibitory activity. The study was performed 
in 8 recurrent idiopathic CaSF and 8 NS. The results 
show that the percentage of "large crystals" is positively 
correlated with a "saturation-inhibition index" (Robert-
son et al., 1976a). Finally, a linear relationship was 
found between the average percentage of large CaOx 
crystals and aggregates excreted by CaSF patients and 
the severity of the disease (Robertson et al., 1981). 
Following these studies, a number of laboratories per-
formed similar PC studies in CaSF. In Great Britain, 
Hallson and Rose (1976) found: "agree in the main with 
these findings although there were striking exceptions". 
In the United States, studies conducted by Crassweller 
et al. (1979) using Robertson's method (not cited) gave 
essentially the same results with both the particle 
volumes and sizes significantly higher in CaSF. 
Recently, in a study of Cx in stone-forming runners, it 
was reported that in stone formers, the volume-size 
distribution curve is trinodal with 3 peaks occurring 
respectively for particle diameters of 2.5, 9 and 25 µm, 
contrary to NS who present only the first peak (Rodgers 
etal., 1991). 
"Opponents": Hartung and Leskovar (1976) stud-
ied an indefinite number of NS and CaSF using the 
Coulter counter technique (Robertson, 1969). There 
was no significant difference in crystal number and 
crystal volume between SF and controls. In another 
study, the poor reproducibility of the PC size-spectrum 
results led the author to stress that this examination is 
"of little use" (Baumann, 1978). 
Cx Studies in CaSF: What are the Common Results? 
Despite many technical and clinical differences, a 
number of studies agree that several Cx parameters ap-
pear significantly different between CaSF and NS. A 
first series concern the particle phase composition and 
their relative frequency. But, the most cited parameter 
is the frequency of "all particles" always higher in CaSF 
as compared to NS (Table 2). This parameter alone un-
derlines the fact that CaSF are more prone to void crys-
talline particles than NS. When the relative frequencies 
are studied as a function of the crystalline phases, wed-
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dellite is the most often observed phase in CaSF; 1t 1s 
found 2 to 4 times more frequently than in NS (Table 
2). Phosphate and urate particles are also observed in 
CaSF contrary to NS (Table 3). Amongst the quantita-
tive particle parameters, the most common results relate 
to the particle size. Using PC, "proponents" agree that 
CaSF voided particles are of larger sizes which can be 
grouped in a peak for sizes greater than 12.2 µm. Us-
ing LM, particle sizes up to 300 µm or more are ob-
served (Table 4). Another parameter of interest might 
be an increased particle aggregate formation ratio (Table 
5). In summary, most "proponents" of Cx studies in 
CaSF agree that CaSF appear more likely than NS to 
present Cx episodes; the crystalline phases are usually 
not observed in NS. These particles are often of larger 
sizes and are in an increased aggregation state. These 
observations favor Cx examinations in these patients. 
They also involve important practical consequences 
regarding the methods, instruments, and protocols used 
for Cx studies in CaSF. 
Discussion 
Cx studies are not performed in most urological 
centers. This is largely due to technical difficulties 
linked with this examination. A relevant Cx method 
should be able to: 1) perform spontaneous Cx studies, 
i.e., to comply with requirements to retain, as near as 
possible, urinary particles in their state at voiding; 2) 
allow a study of the largest range of qualitative and 
quantitative particle parameters; and 3) be compatible 
with routine clinical applications in terms of simplicity, 
speed and associated costs. In this section, we attempt 
to outline such a method for the two main technical steps 
of Cx study, namely urine sampling and instrumental 
analysis. We finally examine the requirements for Cx 
protocols in CaSF. 
Which method for urine sampling, storage and 
handling? 
Urine sampling: Cx studies can be performed on 
early morning as well as on random urine samples that 
are easier to collect (Crassweller et al., 1979; Fazil 
Marickar et al., 1988; Hallson and Rose, 1976). Never-
theless, due to the overnight water restriction period, 
first urine samples of the morning are probably a better 
indicator of the calculogenic property in CaSF and 
should be favored as far as possible (Daudon, 1993). 
Urine storage: Storage periods of less than two 
hours at laboratory temperature give reliable results 
while at the same time being more convenient for pa-
tients and for laboratory work. Nevertheless, due to 
large temperature variations observed in some countries, 
laboratory temperatures during summer may be pretty 
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high and appropriate measures are required for storage 
of the samples. As pH variations in infected samples 
will modify Cx particle parameters, pH of the urines 
must be recorded just after voiding and then at the time 
of study (Daudon et al., 1983; Dyer and Nordin, 1967). 
Urine handling: The less demanding the sample 
preparation, the more possible it is to examine particles 
in their native state. Although there has been no com-
parative study of the effects of filtration, centrifugation 
or drying steps, these time-consuming and costly opera-
tions are likely to affect the particles. In addition, as 
observed during the study of cells in urine sediments, 
methods based on the study of sediments are likely to 
give inaccurate results with poor repeatability (Gadeholt, 
1964; Winkel et al., 1974). 
Which instrument for particle study? 
Particle counting (PC): PC does not allow the 
study of particle qualitative parameters and is restricted 
to the quantitative study of particles. Particle counters 
are standardized using spherical beads whereas most uri-
nary particles are far from being spherical (Figures 1 
and 2). It has been argued that the particle size-distribu-
tion spectra obtained by PC do not put an equal empha-
sis on the counting of all particles regardless of their 
sizes (Ryall and Marshall, 1978). Regarding particle 
quantity deduced from the size-distribution number 
transformed into volume, this can result in errors due to 
the cubic-size relationship involved (Parsons, 1992; 
Ryall and Marshall, 1978). When the number and the 
size pf crystals in urine samples were measured by 
"direct LM" and PC, large discrepancies were found 
between the results of the two methods (Hennequin et 
al., 1991). Finally, for particle identification, another 
method such as LM (Hallson and Rose, 1976; Robertson 
and Peacock, 1972; Robertson et al., 1974) or SEM 
(Rodgers et al., 1991) must be used. 
Petrographic microscopy (PM): PM does not al-
low crystal phase identification of all particles (Hermann 
and Schwille, 1992; Hermann et al., 1991). Particle 
size study is not performed and particle abundancy is 
given using a "crystalluria score", "a gross quantitation 
of the degree of crystalluria" (Wemess et al., 1981). 
PM requires skilled observers not usually found in most 
clinical centers. 
Light microscopy (LM): LM is well suited for 
particle frequency and particle qualitative studies such as 
crystalline phases and crystal habit studies. Regarding 
quantitative aspects, particle size measurements can be 
performed on all particles except for those particles 
whose sizes are less than 1 µm, i.e., below the instru-
ment resolution limit. The largest particle sizes can be 
recorded for each phase. In order to have a more repre-
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sentative evaluation of the particle size-distribution 
spectrum, we define the particle "mean size" as the 
mean of the largest dimensions of the particles belonging 
to the same crystal phase measured in at least twenty 
different optical fields (Daudon, 1987a). Particle 
concentration and number are computed by taking into 
account the slide chamber volume. An estimate of the 
particle volume can be computed for the main crystal 
habits using an unit particle volume by assimilating the 
particle to the nearest simple geometrical volume. This 
method has been useful for the follow-up of patients in 
whom large variations in the volume of the same voided 
crystalline phase occurred (Jouvet et al., 1994). 
Concerning sample preparation, most LM studies are 
performed using "indirect LM" on sediments. "Indirect 
LM" suffers from the same drawbacks as PC and PM 
with regard to the risks for native particle properties, the 
inaccuracy related to work on sediments, and the time 
and costs associated with particle preparation. Thus, 
among all methods used for Cx studies in CaSF, "direct 
LM" appears the best suited in terms of simplicity and 
efficiency for all steps of Cx examinations. 
Which Cx protocol for Cx studies in CaSF? 
Using various Cx protocols and techniques, it has 
been shown that Cx can be reduced as a result of drug 
and diet treatments (Buli et al., 1982; Caudarella et al., 
1986; Cottet and Vittu, 1953; Crassweller et al., 1979; 
Daudon et al., 1987a; Hallson and Rose, 1976; Hallson 
et al., 1976; Robertson et al., 1974, 1976b; Smith, 
1976; Van Den Berg et al., 1976; Valyasevi et al., 
1967, 1973; Wemess et al., 1981). These studies were 
conducted on the simple premise that "if an antistone 
therapy stops crystalluria, it can be expected to retard 
urolithiasis" (Wemess et al., 1981). Using multivariable 
statistical studies, we showed that Cx is the first discrim-
inant variable between CaSF and NS (Chevalier et al., 
in preparation). These results show that Cx is a primary 
significant risk factor in the calcium stone disease and 
the value of Cx studies and attempts for its control in 
CaSF is well founded. 
The question still remains: which Cx protocol must 
be used in order to apply Cx for the follow-up of this 
disease? Obviously, the study of a few samples over a 
short time period is likely to give results without great 
meanings in most patients for whom no etiologic factors 
can be clearly identified (idiopathic CaSF) (Nordin, 
1979). Cx protocols must be used which are able to 
take into account the variability of Cx due both to bio-
logical as well as to technical factors (see Urine 
Sampling and Processing above). Repeated Cx obser-
vations are needed in order to define a patient's "specific 
Cx status", i.e., his Cx frequency, the compositions, 
sizes, aggregation ratios of the voided particles, etc. 
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But, how long and how often must Cx examinations be 
performed in order to give results taking into account Cx 
variability in a patient? Three periods can be distin-
guished when deciding to use Cx examinations in CaSF. 
In the first period, Cx characteristicE" are determined and 
the study is conducted in the absence of treatments as far 
as possible. Next, Cx examinations are used to assess 
the efficiency of a medical treatment, including diet and 
drug treatment, in controlling Cx. After having success-
fully determined these conditions, Cx will be performed 
during the patient follow-up. In order to answer the 
question of the frequency of Cx examinations during 
these periods, comparative and prospective studies are 
needed. It can only be expected that during the follow-
up period, the frequency of Cx examinations will be less 
than in the first two periods in as much as no change in 
the medical status and/or living habits of the patient are 
expected. In any case, many Cx examinations are 
needed, and the possibility of obtaining rapid and 
reliable results using "direct LM" as suggested above is 
of further interest. 
Conclusions 
As early as in the first study analyzed, it was noted 
that crystals can be passed in urine "for years without 
any tendency to calculus formation" (Black, 1945). Lat-
er studies have shown that Cx in CaSF is more frequent 
and is composed of crystalline phases rarely observed in 
NS which tend to form larger particles and aggregates. 
Furthermore, a number of studies have shown that Cx 
can be modified as a result of a medical treatment. 
Thus, Cx examinations are strongly advisable in these 
patients at all stages of the disease. Unfortunately, 
largely due to technical problems, there is at present no 
consensus for the follow-up of CaSF using Cx. Analysis 
of each technique shows that "direct LM" is a simple 
and efficient method. Use of this method in long term 
comparative studies could be of value to further assess 
interest of Cx examination based protocols, in particular, 
for the prevention of stone recurrence in these patients. 
Acknowledgements 
This study was financially supported by the "Caisse 
Nationale d' Assurance Maladie des Travailleurs 
Salaries" CNAMTS, Securite Sociale, France: grant 
number 701039. 
References 
Adamthwaite DN (1983a) Particulate activity in 
urine. Br. J. Urol. 55, 89-94. 
Adamthwaite DN (1983b) Urinary particulate activi-
228 
ty in urinary calculus disease. Br. J. Urol. 55, 95-99. 
Ahlstrand Ch, Tiselius HG, Larsson L (1984) 
Studies on crystalluria in calcium oxalate stone formers. 
Urol. Res. 12, 103-106. 
Baumann JM (1978) Wert der Sedimentunter-
suchung bei Kalziumnephrolithiasis (Value of sediment 
examination in calcium nephrolithiasis disease). 
Fortschr. Urol. Nephrol. ii, 192-195 (in German). 
Baumann JM, Futterlieb A, Lusenberger FX, 
Wacker M (1984) Kristallisationsphiinomene in Human-
urin nach iilimentiirer Oxalatbelastung. Forschrit (Crys-
tallyzation phenomena in human urine after a dietary 
oxalate intake). Urol. Nephrol. 22, 151-155 (in 
German). 
Berg W, Schnapp JD, Schneider HJ, Hesse A, 
Hienzsch E (1976) Crystaloptical and spectroscopical 
findings with calcium oxalate crystals in urine sediment. 
Eur. Urol. 2, 92-97. 
Berlyne GM, Yagil R, Goodwin S, Morag M (1976) 
Drinking habits and urine concentration of man in south-
ern Israel. Israel J. Med. Sci. 12, 765-769. 
Black JM (1945) Oxaluria in british troops in India. 
Br. Med. J. April, 590-592. 
Buli P, Pulini V, Platania A, Petrone U, Brunocilla, 
Martorelli M (1982) Studia della cristalluria come 
metodo di valutazione dell terapia medico-preventive 
della calcolosi renale (Crystalluria studies as a method 
for the follow-up of stone formers). Minerva Nephrol. 
4, 137-150 (in Italian). 
Catalina F, Cifuentes L (1970a) Calcium oxalate: 
Crystallographic analysis in solid aggregates in urinary 
sediments. Science 169, 183-184. 
Catalina F, Cifuentes Delatte L (1970b) Estudio de 
las cristalurias oxalocalcicas (Studies of calcium oxalate 
crystalluria). Arch. Espag. Urol. 25, 147-164 (in 
Spanish). 
Caudarella R, Rizzoli E, Malavolta N, Severi B, 
Vasi V, Biagini G (1986) Cristallurie: un probleme a 
debattre (Crystalluria: a questionable problem). Acta 
Urol. Belg. 54, 49-56 (in French). 
Coe FL, Parks JH, Asplin JR (1992) The patho-
genesis and treatment of kidney stones. New Engl. J. 
Med. 327, 1141-1152. 
Consensus conference: Prevention and treatment of 
kidney stones (1988). J. Am. Med. Assoc. 260, 977-
981. 
Cottet J, Vittu Ch (1952) Valeur semiologique de 
l'epreuve de cristallurie provoquee (Semiological value 
of induced crystalluria). Presse Med. 60, 551-553 (in 
French). 
Cottet J, Vittu Ch (1953) Sediment et lithiase 
urinaire (Urinary sediment and renal lithiasis). Presse 
Med. 61, 703-704 (in French). 
Crassweller PO, Brandes L, Katirtzoglou A, 
Methods for crystalluria studies in calcium stone formers 
Oreopoulos DG (1979) Studies of crystalluria in re-
current calcium lithiasis. Can. J. Surg. 22, 527-529. 
Daudon M (1987a) Cristallurie: Aspects pratiques et 
interpretation. I. Aspects pratiques (Practical aspects of 
crystalluria and interpretation: I. Practical aspects). 
Feuillets de biologie 28, 25-40 (in French). 
Daudon M (1987b) Cristallurie: Aspects pratiques 
et interpretation. II. Interpretation (Practical aspects of 
crystalluria and interpretation: II. Interpretation). 
Feuillets de Biologie 28, 41-47 (in French). 
Daudon M (1989) Methodes d'analyse des calculs et 
des cristaux urinaires (Calculi and urinary crystal 
method analysis). In: Lithiase urinaire II (Urolithiasis). 
Jungers P, Daudon M, Le Due A (eds.). Flammarion 
Medicine Sciences, Paris. 35-113 (in French). 
Daudon M (1993) Criteres d'interpretation d'une 
crystalluria (Interpretation criteria of crystalluria). 
Eurobiologiste 27, 63-72 
Daudon M, Reveillaud RJ (1984) Whewellite et 
weddellite: vers des etiopathogenies differentes. Interet 
du typage morphologique des calculs (Whewellite and 
weddellite: towards different etiopathogeny. Interest of 
morphological studies of the calculi). Nephrol. 5, 195-
205 (in French). 
Daudon M, Protat MF, Reveillaud RJ, Rouchon M 
(1983) Etude de la cristallurie spontanee par spectros-
copie infrarouge. Recherche de correlation entre Jes cris-
taux, les calculs, Jes germes et le sexe des malades 
(Study of spontaneous crystalluria using infrared spec-
trometry. Correlation studies between crystals, calculi, 
bacteria and patient sexes). Ann. Biol. Clin. 41, 199-207 
(in French). 
Daudon M, Jungers P, Reveillaud RJ (1987a) A 
study of crystalluria in calcium oxalate stone patients 
treated with thiazides. In: Contrib. Nephrol. 58, 78-81. 
Daudon M, Reveillaud RJ, Normand M, Petit C, 
Jungers P (1987b) Piridoxilate-induced calcium oxalate 
calculi: A new drug-induced metabolic nephrolithiasis. 
J. Urol. 138, 258-61. 
Daudon M, Reveillaud R J, Levasseur H, Jungers 
P (1989) Combined influence of urinary calcium and 
oxalate concentrations on crystal formation in stone 
formers. In: Urolithiasis. Walker VR, Sutton RAL, Bert 
Cameron EC, Pak CYC, Robertson WG (eds). Plenum 
Press, New York. 155-157. 
Daudon M, Marfisi C, Lacour B, Bader C (1991) 
Investigation of urinary crystals by Fourier transform 
infrared microscopy. Clin. Chem. 37, 83-87. 
Dhanamitta S, Valyasevi A, Van Reen R (1967) 
Studies of Bladder stone disease in Thailand: IX. Effect 
of orthophosphate and fat-free powdered milk supple-
mentation on the occurrence of crystalluria. Am. J. 
Clin. Nutr. 20, 1387-1391. 
Dhanamitta S, Valyasevi A, Van Reen (1970) Stud-
229 
ies of Bladder stone disease in Thailand: XI. Effect of 4-
hydroxy-L-proline and orthophosphate supplementations 
on crystalluria. Am. J. Clin. Nutr. 23, 372-377. 
Dyer R, Nordin BEC (1967) Urinary crystals and 
their relation to stone formation. Nature 215, 751-752. 
Edyvane KA, Hibberd CM, Harnett RM, Marshall 
VR, Ryall RL (1987) Macromolecules inhibit calcium 
oxalate crystal growth and aggregation in whole human 
urine. Clin. Chim. Acta 167, 329-38. 
Elliot JS, Rabinowitz IN (1976) Crystal habit, 
structure and incidence in the urine of hospital popula-
tion. In: Urolithiasis Research. Fleisch H, Robertson 
WG, Smith LH, Vahlensieck W (eds.). Plenum Press, 
New York. 257-260. 
Elliot JS, Rabinowitz IN (1980) Calcium oxalate 
crystalluria: crystal size in urine. J. Urol. 123, 324-327. 
Elliot JS, Rabinowitz IN, Silvert M (1976) Calcium 
oxalate oxaluria. J. Urol. 116, 773-775. 
Fazil Marickar YM, Sachidev K, Thomas J, Sindhu 
S, Vathsala R (1988) Early morning urine versus ran-
dom samples for studying crystalluria. Urol. Res. 16, 
224 (abstract). 
Finch AM, Kasidas GP, Rose GA (1981) Urine 
composition in normal subjects after oral ingestion of 
oxalate-rich foods. Clin. Sci. 60, 411-418. 
Gadeholt H (1964) Quantitative estimation of 
urinary sediments with special regard to sources of 
error. Br. Med. J. 1, 1547-1549. 
Gardner GL (1975) Nucleation and crystal growth 
of calcium oxalate trihydrate. J. Crystal Growth 30, 
158-168. 
Godolphin W, Meagher EP, FrohlichJ, Sanders HD 
(1980) Case 38-1979: Ethylene Glycol Poisoning. New 
Engl. J. Med. 302, 465-466 (letter). 
Hallson PC (1988) Oxalate crystalluria. In: Oxalate 
Metabolism Relation to Urinary Stone, Vol. 9. Rose GA 
(ed.). Springer Verlag, Berlin. 131-166. 
Hallson PC, Rose GA (1976) Crystalluria in normal 
subjects and in stone formers with and without thiazide 
and cellulose phosphate treatment. Br. J. Urol. 48, 515-
524. 
Hallson PC, Rose GA (1977) Seasonal variations in 
urinary crystals. Br. J. Urol. 49, 277-284. 
Hallson PC, Rose GA (1978) A new urinary test for 
stone "activity". Br. Med. J. 50, 442-448. 
Hallson PC, Rose GA (1988) Procedure for the 
measurement of calcium oxalate and phosphate crystals 
in urine. Br. J. Urol. 61, 199-202. 
Hallson PC, Kasidas GP, Rose GA (1976) Urinary 
oxalate in summer and winter in normal subjects and in 
stone-forming patients with idiopathic hypercalciuria, 
both untreated and treated with thiazide and/or cellulose 
phosphate. Urol. Res. 4, 169-173. 
Hartung R, Leskovar P (1976) Studies about crystal-
C.A. Bader et al. 
luria of stone-formers and controls. Experiments on 
crystal growth. In: Urolithiasis Research. Fleisch H, 
Robertson WG, Smith LH, Vahlensieck W (eds.). 
Plenum Press, New York. 289-293. 
Hennequin C, Gaubil J, Bader C, Daudon M, 
Driieke T, Lacour B (1991) Impossibility to study crys-
talluria directly with Coulter counter. Clin. Chim. Acta 
200, 227-229. 
Hermann U, Schwille PO (1992) Crystalluria in 
idiopathic recurrent calcium urolithiasis: Dependence on 
stone composition. Urol. Res. 20, 157-164. 
Hermann U, Schwille PO, Kuch P (1991) Crystal-
luria determined by polarization microscopy: Techniques 
and results in healthy control subjects and patients with 
idiopathic recurrent calcium urolithiasis classified in 
accordance with calciuria. Urol. Res. 19, 151-58. 
Irvine RA, Noakes TD, Rodgers AL, Swartz L 
(1986) Crystalluria in marathon runners 1. Standard 
marathon- Males.· Urol. Res. 14, 289-294. 
Jou vet P, Valogne A, Hubert P, Gagnadoux MF, 
Jan D, Daudon M (1994) Oxalate crystalluria for the 
post hepatic and renal transplantation management in 
primary hyperoxaluria. In: Urolithiasis IL Ryall RL 
(ed.). Plenum Press, New York (in press). 
Khan SR, Hackett RL (1986) Identification of uri-
nary stone and sediment crystals by scanning electron 
microscopy and X-ray microanalysis. J. Urol. 135, 818-
825. 
Klepikov FA, Tomakh YF, Antonyan IM (1991) 
Crystalluria. Urol. Nephrol. (Moscow) 3, 22-25 
Miller W (1990) Ethylene glycol toxicity. Del. 
Med. J. 62, 1267-1271. 
Nancollas GH (1979) The growth of crystals in 
solution. J. Crystal Growth 10, 215-52. 
Nancollas GH (1983) The mechanism of formation 
of renal stone crystals. Proc. EDT A 20, 386-95. 
Nguyen HV, Daudon M, Reveillaud RJ, Jungers P 
(1987) Etude de la cristallurie spontanee chez Jes lithia-
siques oxalo-calciques (Spontaneous crystalluria studies 
in calcium oxalate stone formers). Nephrologie 8, 65-69. 
Nordin BEC (1979) Urinary tract calculi. In: 
Nephrology. Hamburger J, Crosnier J, Griindfeld JP 
(eds.). Flammarion Medicine Sciences, Paris. 1091-
1130. 
Osborne CA, O'Brien TDO, Ghobrial HK, Meihak 
L, Stevens JB (1986) Crystalluria: Observations, inter-
pretations, and misinterpretations. Vet. N. Clin. Am.-
Small Anim. 16, 45-65. 
Parsons DF (1992) A multitasking particle char-
acterization system for laboratory and process control. 
Int. Lab. Sept., 28-32. 
Robertson WG (1969) A method for measuring 
calcium crystalluria. Clin. Chim. Acta 26, 105-110. 
Robertson WG, Peacock M (1972) Calcium oxalate 
230 
crystalluria and inhibitors of crystallization in recurrent 
renal stone-formers. Clin. Sci. 43, 499-506. 
Robertson WG, Peacock M (1984) Metabolic and 
biochemical risk factors in renal stone disease. Contrib. 
Nephrol. 37, 1-4. 
Robertson WG, Peacock M, Nordin BEC (1969) 
Calcium crystalluria in recurrent renal-stone formers. 
Lancet July, 21-24. 
Robertson WG, Peacock M, Nordin BEC (1971) 
Calcium oxalate crystalluria and urine saturation in 
recurrent renal stone-formers. Clin. Sci. 40, 365-374. 
Robertson WG, Peacock M, Knowles F, Nordin 
BEC (1972) Crystalluria, urine saturation and inhibitors 
of crystallisation in the formation of renal stones. In: 
Rein et Calcium (Kidney and Calcium). Hioco D (ed.) 
Sandoz Laboratories, Paris. 307-318. 
Robertson WG, Peacock M, Marshall RW, Knowles 
F ( 1974) The effect of ethane-1-hydroxy-1-1-diphospho-
nate (EHDP) on calcium oxalate crystalluria in recurrent 
renal stone formers. Clin. Sci. Mol. Med. 47, 13-22. 
Robertson WG, Peacock M, Marshall RW, Marshall 
DH, Nordin BEC (1976a) Saturation-inhibition index as 
a measure of the risk of calcium oxalate stone formation 
in the urinary tract. New Engl. J. Med. 294, 249-252. 
Robertson WG, Peacock M, Marshall RW, 
Vamavides CK, Heyburn PJ, Nordin BEC (1976b) Ef-
fect of orthophosphate on calcium crystalluria in stone 
formers. In: Urolithiasis Research. Fleisch H, Robertson 
WG, Smith LH, Vahlensieck W (eds.). Plenum Press, 
New York. 229-342. 
Robertson WG, Scurr DS, Bridge CM (1981) Fac-
tors influencing the crystallisation of calcium oxalate in 
urine-critique. J Crystal Growth 53, 182-94. 
Rodgers AL, Greyling KG, Irving RA, Noakes TD 
(1988) Crystalluria in marathon runners. IL Ultra 
marathon-males and females. Urol. Res. 16, 89-93. 
Rodgers AL, Greyling KG, Noakes TD (1991) 
Crystalluria in marathon runners. III. Stone forming 
subjects. Urol. Res. 19, 189-192. 
Rodgers AL, Cox TA, Noakes TD, Lombard CJ 
(1992) Crystalluria in marathon runners. IV. Black 
subjects. Urol. Res. 20, 27-33. 
Ryall RL, Marshall VR (1978) A reappraisal of the 
Coulter counter technique for measuring calcium oxalate 
crystal size. Clin. Chim. Acta 83, 99-107. 
Schwille PO (1985) Urolithiasis research - Where is 
it going? Urol. Res. 13, 157-159. 
Smith LH (1976) Application of physical, chemical 
and metabolic factors to the management of urolithiasis. 
In: Urolithiasis Research. Fleisch H, Robertson WG, 
Smith LH, Vahlensieck W (eds.). Plenum Press, New 
York. 199-211. 
Smith LH (1989) The medical aspects of urolithia-
sis: An overview J. Urol. 141, 707-710. 
Methods for crystalluria studies in calcium stone formers 
Sriboonlue P, Prasongwattana V, Sriboonlue M, 
Chata K, Tungsanga K, Sitprija V (1990) Low specific 
gravity urine with crystalluria as discriminant index for 
nephrolithiasis. J. Med. Assoc. Thai. 73, 634-640. 
Terlinsky AS, Grochowski J, Geoly KL, Strauch 
BS, Hefter L (1980) Monohydrate calcium oxalate crys-
talluria in ethylene glycol poisoning. New Engl. J. Med. 
302, 922 (letter). 
Terlinsky AS, Grochowski J, Geoly KL, Strauch 
BS, Hefter L (1981) Identification of a typical calcium 
oxalate crystalluria following ethylene glycol ingestion. 
Am. J. Clin. Pathol. 76, 223-26. 
Tiselius HG (1991) Aspects on estimation of the risk 
of calcium oxalate crystalliz.ation in urine. U rol. Int. 47, 
255-259. 
Tomazic BB, Nancollas GH (1979) A study of the 
phase transformation of calcium oxalate trihydrate-
monohydrate. Invest. Urol. 16, 329-335. 
Tozuka K, Yonese Y, Konjiki T, Sudo T (1987) 
Study of calcium phosphate crystalluria. J. Urol. 138, 
326-329. 
Valyasevi A, Dhanamitta S (1974) Studies of 
bladder stone disease in Thailand: XVII. Effect of 
exogenous source of oxalate on crystalluria. Am. J. 
Clin. Nutr. 27, 877-882. 
Valyasevi A, Halstead SB, Dhanamitta S (1967) 
Studies of Bladder stone disease in Thailand: VI. 
Urinary studies in children, 2-10 years old resident in a 
hypo- and hyperendemic area. Am. J. Clin. Nutr. 20, 
1362-1368. 
Valyasevi A, Dhanamitta S, Van Reen R (1973) 
Studies of bladder stone disease in Thailand: XVI. 
Effect of 4-hydroxy-L-proline and orthophosphate 
supplementations on urinary composition and 
crystalluria; Am J. Clin. Nut. 26, 1207-1211. 
Van Den Berg CJ, Cahill TM, Smith LH (1976) 
Crystalluria. In: Urolithiasis Research. Fleisch H, 
Robertson WG, Smith LH, Vahlensieck W (eds.) 
Plenum Press, New York. 365-366. 
von Sengbusch R, Timmermann A (1957a) Das 
kristalline Calciumoxalat im menschlichen Ham und 
seine Beziehung zur Oxalatstein-Bildung (Calcium oxa-
late crystalluria in human renal stone diseases and rela-
tionships with calculi composition). Urol. Int. 4, 76-95 
(in German). 
von Sengbusch R, Timmermann A (1957b) Die 
bildung von Calciumoxalat-Mikrosteinen im menshlichen 
Ham und ihre Veriinderungen durch diatetische und 
medikamentose Massnahmen (Formation of calcium oxa-
late microcalculi in human stone disease. Influence of 
diet and therapy). Urol. Int. 5, 218-231 (in German). 
von Sengbusch R, Timmermann A (1958) Kristal-
line vorstadien der kalziumoxalatsteine im menschlichen 
Ham: ihre Abhiingigheit von der Diatprophylaxe und der 
231 
Therapie (Crystalluria studies in human calcium oxalate 
urinary stones: Relationships with diet and therapy). 
Dtsch. Med. Wschr. 83, 501-504 (in German). 
Wemess PG, Bergert JH, Smith LH (1981) 
Crystalluria. J. Crystal Growth 53, 166-181. 
Wemess PG, Brown CM, Smith LH, Finlayson B 
(1985) Equil2: a basic computer program for the calcu-
lation of urinary saturation. J. Urol. 134, 1242-1244. 
Winkel P, Statland BE, Jorgensen K (1974) Urine 
microscopy, an ill-defined method examined by a multi-
factorial technique. Clin. Chem. 20, 436-439. 
Winkens RAG, Wielders JPM, Degenaar CP, Van 
Hoof JP (1988) Calcium oxalate crystalluria, a curiosity 
or a diagnostical aid. J. Clin. Chem. Clin. Biochem. 26, 
653-654 (letter). 
Discussion with Reviewers 
R. Tawashi and M. Akbarieh: From your experience, 
what is the most critical variable in writing a protocol 
for Cx studies using LM? 
Authors: There are several critical variables which 
have to be fulfilled in order to perform reliable Cx 
studies in CaSF. The first critical variable is to study 
the urinary crystalline particles in a state as near as 
possible to voided, i.e., to perform "spontaneous" Cx 
studies. It should be noted that this requirement is 
applicable irrespective of techniques and instrument 
used. However, taking into account the numerous han-
dling steps required by all other methods including 
"indirect LM", only "direct LM", which does not re-
quire any urine preparation steps, "is able to fulfill, at 
best, the conditions of "spontaneous" Cx studies. 
Two other requirements are also independent of the 
chosen Cx technique: the need to perform repetitive 
"spontaneous" Cx studies and the need to select a set of 
reference Cx parameters. Due to patient as well as 
healthy subject variability, only repetitive studies can 
define the qualitative and quantitative Cx parameters 
with a statistical value: molecular phases voided and 
their frequencies, particle sizes, aggregation ratio, etc. 
Obtaining one or even a few Cx results in a patient is 
likely to have, in most cases, only no more than an an-
ecdotic value in particular for idiopathic calcium nephro-
lithiasis patients. The third critical variable is linked to 
the need of having a reference set of Cx parameters. 
One must choose between basing this reference set on a 
strictly defined patient cohort or on the patient himself. 
Due to the difficulty in controlling all parameters (age, 
sex, calcium nephrolithiasis etiology, stage of the dis-
ease, regimen, diet, drugs, etc.), using the patient as his 
or her own reference is often the most accurate and 
practical way for using Cx studies in patient follow-up. 
Only in the case of large comparative studies, can sever-
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al patient series be used. We take this opportunity to 
stress that in most cases, statistical requirements are 
such that the number of patients and urine samples re-
quired, combined with the long time associated with 
most recurrent stone events, strongly appeal for coopera-
tive studies between stone clinics on a national, or when 
possible, an international basis. 
R. Tawashi and M. Akbarieh: In your view, what 
would be the role of crystal phase transition in Cx deter-
mination or the interpretation of results obtained, partic-
ularly when it comes to the storage and/or filtration of 
urine? 
Authors: As strongly advocated in our paper and re-
peated above, we think that clinically meaningful Cx 
studies must be "spontaneous" Cx studies. Other Cx re-
sults need careful evaluation as to whether the results of 
Cx changes are the consequences of particle preparation 
steps such as filtration, storage, dilution, etc., or are 
they the results of physicochemical steps such as cool-
ing, pH adjustments, etc. Nevertheless, well-controlled 
physicochemical treatments are easier to interpret than 
the variations of Cx parameters due to the handling 
steps. We have some experience on the modifications of 
Cx parameters of urine samples after 48 to 72 hours 
storage at 4 °C. We always perform these studies after 
having first studied the urine samples immediately after 
voiding, i.e., their "spontaneous" Cx parameters. Re-
sults of our studies (unpublished) can be summarized as 
follows. The main interest of crystal phase transitions 
observed after urine storage in the cold is the study of 
the relationships between crystal phases and the bio-
chemical composition of urine. Depending on the urine 
supersaturation level, crystalline phase transitions will 
occur more or less rapidly. For instance, when urine 
pH is low, namely less than 5.2, uric acid dihydrate 
crystals can form in urine despite low urate concentra-
tion (1-1.5 mmol/1). This crystal phase may be either 
stable or able to transform into anhydrous uric acid 
crystals depending on the supersaturation level. In 
contrast, if urine pH is higher than 5.5, precipitates of 
complex amorphous urates rather than uric acid dihy-
drate may occur in cases of high urate concentration ( > 
4 mmol/1). In such conditions, the formation of uric 
acid dihydrate crystals will occur progressively at the 
expense of disappearing amorphous urates. 
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